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Abstract
Background: Since the advent of smartphones, mHealth has risen to the attention of the health care system as something that
could radically change the way health care has been viewed, managed, and delivered to date. This is particularly relevant for
cancer, as one of the leading causes of death worldwide, and for cancer supportive care, since patients and caregivers have key
roles in managing side effects. Given adequate knowledge, they are able to expect appropriate assessments and interventions. In
this scenario, mHealth has great potential for linking patients, caregivers, and health care professionals; for enabling early detection
and intervention; for lowering costs; and achieving better quality of life. Given its great potential, it is important to evaluate the
performance of mHealth. This can be considered from several perspectives, of which organizational performance is particularly
relevant, since mHealth may increase the productivity of health care providers and as a result even the productivity of health care
systems.
Objective: This paper aims to review studies on the evaluation of the performance of mHealth, with particular focus on cancer
care and cancer supportive care processes, concentrating on its contribution to organizational performance, as well as identifying
some indications for a further research agenda.
Methods: We carried out a review of literature, aimed at identifying studies related to the performance of mHealth in general
or focusing on cancer care and cancer supportive care.
Results: Our analysis revealed that studies are almost always based on a single dimension of performance. Any evaluations of
the performance of mHealth are based on very different methods and measures, with a prevailing focus on issues linked to
efficiency. This fails to consider the real contribution that mHealth can offer for improving the performance of health care
providers, health care systems, and the quality of life in general.
Conclusions: Further research should start by stating and explaining what is meant by the evaluation of mHealth’s performance
and then conduct more in-depth analysis in order to create shared frameworks to specifically identify the different dimensions of
mHealth’s performance.
(J Med Internet Res 2015;17(2):e9)  doi: 10.2196/jmir.3764
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Introduction
Health care is undergoing an evolutionary phase worldwide
aimed at facing multiple challenges: (1) the aging global
population is increasingly affected by chronic diseases for much
longer [1,2], (2) health care delivery costs are becoming
unsustainable [3], (3) societies are becoming more and more
mobile [4], and (4) being cared for at home is increasingly the
preferred mode of health care delivery [2,5]. The
unsustainability of current health care spending has led to the
need for disruptive solutions, capable of controlling costs
without diminishing quality of service and quality of life.
Chronic diseases are becoming the heaviest burden on health
care systems worldwide, and cancer is one of these. A chronic
disease can be defined as a condition that lasts a year or longer
and requires ongoing monitoring and treatment [6]. Although
cancer continues to be one of the main causes of death, efforts
have been made in several fields of medicine in order to reduce
cancer mortality every year [7].
This scenario has witnessed the rapid and ongoing growth in
mobile technologies, especially mobile health (mHealth) defined
as “medical and public health practice supported by mobile
devices, such as mobile phones, patient monitoring devices,
personal digital assistants (PDAs), and other wireless devices”
[8]. According to this definition, mHealth includes short
messaging services (SMS) as well as more complex applications
like general packet radio service (GPRS), third and fourth
generation mobile telecommunications (3G and 4G systems),
global positioning systems (GPS), and Bluetooth technology
[8].
Furthermore, major advances have been carried out into two
subfields: wearable and body area sensor networks, and mobile
broadband and wireless Internet mHealth systems [9]. An
example of the former is the innovative WE-CARE system: an
intelligent telecardiology system that exploits mobile wireless
networks in order to provide benefits in detection rate and time
savings [10]. An example of the second subfield is the concept
of 4G health. The introduction of the fourth-generation mobile
communication system led to a turning point and “the evolution
of mHealth towards targeted personalized medical systems with
adaptable functionalities and compatibility with the future 4G
networks” [9]. The prospect of managing health care via mobile
platforms has resulted in a momentous technology drive and
the implementation of thousands of mobile apps, mainly
designed for a single condition or aspect of disease management.
Over the past decade, especially since the advent of
smartphones, mHealth has come to the attention of the health
care system as something that could radically change the way
health care has been viewed, managed, and delivered to date.
By exploiting their technical capabilities, mobile phones can
be used to implement several health care interventions, ranging
from increasing the accessibility of health care information (eg,
short messages or reminders) to involving the health care team
(eg, remote monitoring) [11]. To this extent, a mobile phone
with a wireless connection is an essential prerequisite because,
as Huang et al state: “a wireless network may be not mobile,
but a mobile network must be wireless” [10]. In the case of
cancer, hundreds of apps have already been designed and
implemented with several purposes, such as raising awareness
about chronic disease, providing information about cancer, or
for managing cancer [12].
mHealth has generated a surge of positivistic policy documents,
such as the Digital Agenda for Europe [13] and the Federal
Health IT Strategic Plan [14] in the United States, and this
emerging industry has attracted large investments. mHealth
makes it possible to follow the shifting focus of health care from
“cure” to “care” thanks to its tendency to support the entire care
process, including wellness and prevention. This is important
in the case of cancer, one of the leading causes of death
worldwide, accounting for 8.2 million deaths in 2012 [15].
mHealth may play a particularly significant role in cancer
supportive care, dealing with the management of the side effects
of cancer treatment, since patients and caregivers play a role in
managing side effects and, given adequate knowledge, are able
to demand appropriate assessments and intervention. In this
scenario, mHealth has great potential for linking patients,
caregivers, and health care professionals, for enabling early
detection and intervention, for cutting costs, and achieving better
quality of life.
Given its huge potential, it is important to evaluate the
performance of mHealth. Literature has shown that the
performance of mHealth can be assessed from several
perspectives. It can be seen as a return on integrated care
processes, since it can improve communication and enhance
integration among those involved in health care processes
[16,17]. In terms of organizational performance, mHealth can
increase the productivity of health care providers and possibly
even the productivity of health care systems as a result [18-20].
For external relations, mHealth can enhance transparency,
increasing the accountability of health care providers and
systems [21,22], and it can also empower patients [1,23-25].
Finally, the greatest promise of mHealth is that it may boost the
appropriateness of care and possibly the quality of life [26,27].
This paper intends to review studies on the evaluation of the
performance of mHealth, with a particular focus on cancer care
and cancer supportive care processes, concentrating on its
contribution to organizational performance. It also aims to
identify elements for a further research agenda.
Methods
We carried out a review of papers from three bodies of literature:
medical informatics, health care management, and medicine,
with particular reference to oncology journals. The first step of
our research strategy (Table 1) was aimed at identifying and
collecting all existing studies on the evaluation of mHealth’s
performance in cancer and cancer supportive care. We started
by identifying a number of keywords and entered them in our
selected computerized bibliographical databases, resulting in a
total of 1698 papers, including 106 that were relevant in terms
of mHealth and performance and were used for our assessment.
We then narrowed down this result to cancer supportive care,
leading to a total of 67 papers, including 15 that were useful for
our analysis.
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We subsequently used a “bibliographic network approach” to
track the articles in the references in the works we considered
fundamental for our research. We retrieved papers and studies
published after 1999 in academic reviews and journals that were
not listed in the database at the time of the analysis, but which
were known among academics.
Table 1. Research strategy to identify and collect relevant studies.
Detailed informationSearch strategy
Generic search using concept words: “mHealth”, “cancer”, “quality of life”, Specific searches : “mHealth” (mHealth OR
mHealth OR “mobile health” OR “mobile health care”) + “cancer” (cancer OR “cancer care” OR “cancer supportive care”
OR “supportive care in cancer” OR “chemotherapy” OR “side effects” OR “adverse effects” OR “integrated care” OR
“cancer integrated care”) + “Quality of life” (“quality of life” OR “quality of service” OR “quality of care” OR “health
care delivery” OR “health care management” OR “care management” OR “health policy” OR promises OR “continuity
of care” OR “lean health care” OR “lean health care” OR “lean thinking” OR “patient-centered”) + “performance” (“per-
formance” OR “evaluation” OR “impact” OR “assessment” OR “return” OR “promises” OR “adoption”)
Keywords
BioMed Central, Business Source Complete, IEEE Xplore, PLOS (One, Medicine and Clinical Trials), PubMed, Science
Direct, Web of Science (which embeds Elsevier, Wiley, JMIR, JAMIA), Cochrane Library
Databases
JAMIA, JMIR, BMJ, Health affairs, Health care management review, Health Policy, Health Policy and Technology, Value
in Health (ISPOR), Journal of Cancer Policy, Academy of Management Journal, Journal of Management studies, Journal
of Health Economics, Health economics, Canadian Medical Association Journal, Health Informatics Journal, Journal of
Clinical Oncology (ASCO), Annals of Oncology (ESMO), Supportive Care in Cancer (MASCC), European Journal of
Cancer (published by Elsevier, official journal of EORTC, ECCO, EACR and EUSOMA), Critical Reviews in Oncology
and Hematology (ESO), Health Services Management Review (EHMA), IEEE Journal of Biomedical and Health Infor-
matics, IEEE Transactions on Information Technology in Biomedicine, Journal of Biomedical Informatics
Specific journals
Peer-reviewed published articlesInclusion criteria
Published since 1999
Grey literature (blogs, newsletters, videos)Exclusion criteria
Provisional or structured abstracts
Poster sessions, presentations, comments, opinions, discussions, editorials, prefaces, summaries, interviews, correspondence,
tutorials
Studies focused only on (1) design of the device or the app, (2) technology (communication and Web protocols, standards,
platforms), and (3) characteristics of the technology (eg, wireless technology, bandwidth, battery life, connectivity, signal
quality)
Studies on psychology, ie, behavioral models and theory of psychology
Studies on definition of new quality of life measurements as influenced by the technology
Studies set in low resource settings or developing countries, except when talking about implementation of new technologies
in low resource settings (sustainability, etc)
Studies where mobile health means mobile clinics or mobility of professionals or mobile screening units
Studies or articles with no author
Studies or articles with no abstract
Results
Performance of mHealth
Study Characteristics
Our first finding is that there is a very limited amount of
literature on mHealth’s performance. Our analysis revealed that
only 35.8% (38/106) of our selected papers looked at mHealth’s
performance in some way, as most of the studies focused on
the use of mHealth, and less on adoption and its determinants
and barriers.
More frequently, studies offered an assessment of the
performance of technology rather than an evaluation of the
contribution to organizational performance and the quality of
life of patients. According to the categorization provided by the
World Bank [8], countries can be classified according to three
“income-classes”: high, medium, and low income. Most studies
referred to high income countries (61%, 28/38 papers) and less
to low income (8%, 3/38 papers) and middle income countries
(5%, 2/38 papers). We should mention that 13% of papers
referred to different type of countries (5/38 papers) and 13%
(5/38 papers) of our selected studies did not refer to any specific
country or region (Figure 1) since their contribution was based
on a literature review with no specific reference to any country.
Most papers were empirical in methodology (about 73%, 28/38
papers) (see Figure 2). Other specific methodologies were used,
some taking a more qualitative research design, such as literature
review, case studies, tool description, and focus groups.
However, most were based on more quantitative designs, like
randomized controlled trials, systematic reviews, surveys, and
pilot studies.
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Looking in greater depth at the health condition under analysis
(Figure 3), only 5% (2/38 papers) of the papers focused on acute
care, 18% (7/38 papers) did not focus on any specific condition,
and the majority of papers (77%, 29/38 papers) looked at chronic
care. Chronic care includes cancer and cancer supportive care,
which accounted for 37% (14/38 papers) of the papers on
performance in our analysis, as well as several other diseases,
such as asthma, diabetes, and obesity.
Looking at the type of mobile technologies analyzed relating
to performance, 61% (23/38 papers) of papers discussed mobile
devices (like smartphones and tablets) and apps, 18% (7/38
papers) remote monitoring technologies, 37% (14/38 papers)
SMS technologies, and only 3% (1/38 paper) focused on
telehealth (Figure 4). We should mention that some papers
referred to several types of mobile technologies.
Figure 1. Type of country.
Figure 2. Methodology of studies.
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Figure 3. Health condition.
Figure 4. Type of technology.
Evaluation of mHealth’s Performance
The assessment of mHealth’s performance is based on the use
of multiple measures. It is mainly measured in terms of better
quality information [3,16,17,28-30]. Baumgart analyzed
information-sharing, showing that the quality of information
increased for certain activities as a result of using PDAs and
tablets, such as billing, prescription writing, medical calculation,
scheduling, and drug reference [31]. A study by Hamou et al
showed that using mobile technologies for collecting patient
data and feedback could promote better information when used
in a clinical setting [20].
Another measure of performance often analyzed is cost savings
[25,32,33]. A report by Boston Consulting Group and Telenor,
for example, analyzed the role of mHealth in homecare for the
elderly [34]. According to this report, costs savings for caring
for the elderly varied in three different countries, with amounts
ranging from €1.25 billion in Denmark to €2.4 billion in
Sweden.
Other studies have shown that mHealth may make patient
assessment more straightforward and less time consuming
[17,35,36]. Some studies examined mHealth’s performance
with respect to improvements in medical treatment adherence
rates [37,38] and consequent re-hospitalization rates [39-41].
Other papers studied the quality of service [42-44], but they
often had a specific and narrow scope of mHealth use (eg,
mHealth offers patients improved mobility and comfort thanks
to wireless technology) [45]. Some papers analyzed mHealth’s
performance by looking at the enhanced monitoring of patients
that also led to better disease management [46].
Using mobile technologies to collect up-to-date data can help
patients regain functional independence and help hospitals
determine the appropriate length of stay for a patient [47] and
thus help cut the cost of hospitalization [25]. Finally, some
studies have shown that health care communities created via
mHealth can enhance quality of life by providing peer support,
whereby patients are able to exchange opinions with regard to
a certain drug, physician, therapy, or share personal experiences
[27,48].
Discussion of Findings
Although there is not necessarily a common assessment of the
measures of performance to be found in literature, they can be
grouped into main dimensions based on other studies assessing
innovation and technological innovations [49,50]. For instance,
papers that measured performance in terms of the quality of
information, cost savings, and time savings actually focused on
efficiency measures [21]. Other studies related to effectiveness
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[39,51], and some of these focused on dimensions of
organizational performance from the health care provider’s
viewpoint. In particular, the focus was on cutting
re-hospitalization rates or other indirect effects associated with
improved integration of health care. With regard to
effectiveness, another limited body of research focused on
quality of service. Finally, very few papers analyzed clinical
effectiveness in public health [26] and the role of mHealth for
enhancing quality of life [26].
In particular, research considering quality of life focused on a
single dimension, that is, enhancing the social relationships of
patients. However, quality of life was typically associated with
other dimensions, like a person’s physical health, psychological
state, level of independence, personal beliefs, and local
environment [52].
Performance of mHealth in Cancer Care
We subsequently studied papers assessing the performance of
mHealth in cancer supportive care. Unfortunately, there were
very few papers on this important care process (5.6% of total
papers, 6 papers), and so we extended our analysis to include
all papers assessing mHealth’s performance in cancer care.
These studies were mainly empirical, and most of them
identified similar measures of performance (Figure 5).
First, the dimensions discussed above must be defined [53].
The framework consists of four performance dimensions:
efficiency and effectiveness, which are output measures, and
clinical effectiveness and quality of life, which are outcome
measures.
Efficiency focuses on the evaluation of mHealth in terms of
quality of information, time saving, and cost savings.
Effectiveness is related to the contribution that mHealth gives
to the process of integration and improvement of patient care
processes, evaluated from the health care provider’s perspective.
To this extent, this dimension can be divided into two measures,
namely organizational performance and quality of service.
Clinical effectiveness deals with the evaluation of the effects
produced on clinical activities, such as improvements in the
adherence rate to medical treatment. Finally, quality of life
measurements refer to the evaluation of mHealth in terms of
physical and psychological state.
Figure 6 shows the different measures of performance of
mHealth in cancer care grouped by these dimensions.
Figure 5. mHealth performance in cancer and cancer supportive care: empirical studies.
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Figure 6. Dimensions and measures of mHealth performance in cancer care.
Efficiency
Most papers focused on better quality information with respect
to efficiency [4,54]. A 2001 study, for example, found that many
clinical procedures relating to patient management are repetitive
and Workflow Management Systems for oncology can automate
these repeated activities by using mobile applications to transfer
data services, like remote monitoring. Workflow implies the
automation of business processes in order to promote the
transition of information within the organization and can enable
health care institutions to transform large amounts of medical
data into contextually relevant clinical information [28].
Literature on mHealth’s performance in cancer analyzed other
measures of efficiency, including cost savings [2,54] and time
savings [54,55]. Holzinger analyzed the impacts of a new
method for collecting skin cancer data [54]. Patients filled out
a questionnaire on a tablet personal computer, and the medical
data collected became part of the electronic patient record made
directly available to physicians. The author found this instrument
generated annual savings worth up to €40,000 compared to the
estimated annual cost of €55,000 if mHealth were not used.
Holzinger’s research [54] also showed another measure of
efficiency, that is, time savings. His study actually found data
indicating up to 90% reduction in the time needed for data entry.
This may be particularly significant if mHealth can make it
possible to save time by sharing information generated by central
hospitals located in big cities with remote care centers [55].
Furthermore, ready access to patient data by means of mobile
devices and technologies can lead to a significant reduction in
medical errors.
Effectiveness
Quality of service is one measure of effectiveness [56-58].
Lamber et al showed how mobile technologies can help monitor
oncological patients during day hospital therapies if a mobile
service is an integral part of the hospital’s information system.
This instrument guides patients at hospital by means of a
“patient guidance service” telling them what they have to do
next [56].
Many papers, however, focus on better monitoring, especially
those related to cancer supportive care [5,23,59]. For example,
Kearney evaluated the impact of a remote monitoring system
based on mobile technology assessing the effects of six common
side effects of chemotherapy [23]. In the same way, Mooney
tested the feasibility of a telephone-based computerized system
used for monitoring chemotherapy symptoms by generating
alerts to health care providers [59]. More specifically, Mooney
illustrated the usefulness of mHealth for assessing less common
symptoms that are usually poorly controlled.
Clinical Effectiveness
Clinical effectiveness seems to be mainly related to the
appropriateness of care, often measured through the adherence
rate to medical treatment [26,60]. Heinrich evaluated the use
of handheld devices that provide electronic reminders for
medication to a sample of adults suffering chronic illness [26].
Moreover, adherence to medical treatment may be improved
through a software app developed for a mobile phone platform
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to support regular and correct drug intake, also leading to better
disease management [60].
Quality of Life
Finally, quality of life is a poorly investigated dimension of
performance with specific reference to cancer. We found only
two papers assessing this dimension, which examined several
chronic conditions, including cancer [51,61]. They discussed
the contribution of mHealth to a patient’s health and behavior
in general terms.
Discussion
Principal Findings
This paper helps investigate the performance of mHealth, with
particular reference to mHealth in cancer supportive care.
Although there is abundant literature on mHealth, it is lacking
with regard to mHealth’s performance, especially in relation to
cancer and cancer supportive care. Most mHealth studies focus
more on the mobile technology itself, rather than on its adoption
and performance, as confirmed by Van Heerden et al [62].
However, introducing systems like mHealth for managing health
care-related information is not limited to technology, since it
demands the capacity to integrate technology, people, and
processes.
Most papers that we reviewed focused on the use of mHealth,
some looked at the performance of mHealth, and very few
papers looked at the determinants of mHealth. The papers on
the early stages of the innovation process actually focused on
pilot projects rarely leading to wide-scale adoption. Pilot studies
have been carried out, and mobile apps have been developed
and tested on specific contexts. According to Tomlinson et al
[63], there are more than 500 mHealth studies on pilot projects,
but almost nothing is known about the likely uptake of these
initiatives after the pilot projects are completed. As a result, it
is clear that there are huge scaling-up problems.
If we have to determine whether mHealth can actually meet its
promise, our analysis found very limited evidence when it comes
to mHealth in general and its contribution to better quality of
life. Research is almost always based on single studies and on
a single dimension of return. For example, papers often do not
analyze efficiency, but focus on cost- or time savings. Any
evaluation of the performance of mHealth is based on very
different methods and measures, with a prevailing focus on the
quality of information. This fails to consider the contribution
that mHealth may offer to improving the performance of health
care providers, health care systems, and to quality of life in
general.
Technically, there is little evidence of evaluation processes
based on structured, solid, consistent, and mature methodologies.
Furthermore, the evaluations were not part of larger and more
extensive performance measurement processes, starting with
defining goals for mHealth supporting a given health care
process, cancer care processes in particular, and then
systematically and continuously analyzing what happens next.
This approach to evaluation is crucial because effects may not
necessarily be evident immediately after the introduction of
innovation; evaluation should be monitored over time to allow
for effects that become visible in the short, medium, and long
term.
The existing literature also usually involved a single specific
stakeholder, whereas our vision takes in multiple types of
stakeholders [64,65] working in this specific field, who all
perceive benefits resulting from their involvement. Thus, all
these benefits should be analyzed.
Possible Future Research Agenda
Overview
This paper is a preliminary study that analyzes the performance
of mHealth in cancer supportive care. To date, there is limited
published research in this field. Consequently, we identified
some areas for further research.
Systematic Review of Definitions for the Evaluation of
mHealth’s Performance
A first substantial contribution to assessing mHealth’s
performance would be a systematic assessment and review of
the current definitions of the scope and boundaries of the
evaluation processes. In the private sector, a substantial body
of empirical and theoretically informed research has led to
discussion on return of investment measures and key
performance and success indicators. A main motivation for
evaluation is the need to monitor profitability results, in turn
providing an incentive for further innovation in order to cut
costs and improve market share, which fits the purpose of some
higher-income countries with private health care systems.
However, the adoption of mHealth is generally supported for
more general purposes, such as improving the efficiency,
productivity, and adequacy of care services. This leads to
benefits going beyond organizational results, with more
social-related outputs and outcomes, and impacts such as quality
of life.
Development of Solid Frameworks to Measure the
Performance of mHealth
There is a prevailing focus on empirical studies, each adopting
its own measures of performance. Theoretical studies should
be carried out in order to better understand the performance of
mHealth. There is a need to develop and consolidate more
systematic frameworks since most studies focus on single
measures of performance, although we grouped them into
dimensions, with the aim of providing measurement systems
of mHealth performance. This is fundamental for depicting
results and for creating opportunities for comparing evidence
and generalizing findings.
Multi-Stakeholder Expectations and Multi-Stakeholder
Assessment of mHealth Performance
mHealth is a technological innovation that could affect multiple
stakeholders. This has at least two implications for a research
agenda. First, it suggests an investigation of the expectations
of stakeholders with the purpose of prioritizing mHealth
adoption where there is a need for it. This may lead to favorable
and supportive opinions relating to the adoption process and to
the identification of mechanisms to generate value and stimulate
commitment towards mHealth. Second, evidence regarding the
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expectations of stakeholders should be considered in order to
set goals and define targets for results that should be reflected
in the measurement frameworks.
Systematic Performance Measurement Cycles
Most studies analyzed were based on empirical work on pilot
projects and tests of mHealth adoption. Evidence [63] suggests
that this does not always lead to wide-scale adoption. Literature
on performance measurement [49,50] suggests that evaluating
innovation performance should be an ongoing activity. Not all
effects of mHealth embedded in a care process may be
measurable at the same time. Most technological innovations
produce multiple effects at different times after adoption [66-68],
so it seems relevant to systematically and repeatedly collect
data on the impacts of this innovation.
Methods
Some studies [43,59] are based on perceptions and limited
interviews. Further research should address the question of
methods that are more fit for purpose.
Finally, it seems appropriate to link the evaluation of mHealth’s
performance to the scope and use of mHealth. This might
provide an honest assessment of the actual contribution that
mHealth can offer.
Conclusions
Our analysis revealed that studies evaluating the performance
of mHealth are based on very different methods and measures,
with a prevailing focus on issues linked to efficiency. This fails
to consider the real contribution that mHealth can offer for
improving the performance of health care providers, health care
systems, and the quality of life for patients.
Acknowledgments
The authors would like to express their gratitude to Helsinn Group, sponsor of the conference “mHealth for improving quality
of life. Enhancing cancer supportive care”, for which this research was conducted.
Conflicts of Interest
None declared.
References
1. Honka A, Kaipainen K, Hietala H, Saranummi N. Rethinking health: ICT-enabled services to empower people to manage
their health. IEEE Rev Biomed Eng 2011;4:119-139. [doi: 10.1109/RBME.2011.2174217] [Medline: 22273795]
2. Takizawa M, Sone S, Hanamura K, Asakura K. Telemedicine system using computed tomography van of high-speed
telecommunication vehicle. IEEE Trans. Inform. Technol. Biomed 2001;5(1):2-9. [doi: 10.1109/4233.908348]
3. Jiménez-Mixco V, Cabrera-Umpiérrez MF, Arredondo MT, Panou AM, Struck M, Bonfiglio S. Feasibility of a wireless
health monitoring system for prevention and health assessment of elderly people. In: Conf Proc IEEE Eng Med Biol Soc.
2013 Presented at: 35th Annual International Conference of the IEEE, Engineering in Medicine and Biology Society
(EMBC); July 3-7, 2013; Osaka, Japan p. 7306-7309. [doi: 10.1109/EMBC.2013.6611245]
4. Free C, Phillips G, Watson L, Galli L, Felix L, Edwards P, et al. The effectiveness of mobile-health technologies to improve
health care service delivery processes: a systematic review and meta-analysis. PLoS Med 2013;10(1):e1001363 [FREE
Full text] [doi: 10.1371/journal.pmed.1001363] [Medline: 23458994]
5. Kearney N, Kidd L, Miller M, Sage M, Khorrami J, McGee M, et al. Utilising handheld computers to monitor and support
patients receiving chemotherapy: results of a UK-based feasibility study. Support Care Cancer 2006 Jul;14(7):742-752.
[doi: 10.1007/s00520-005-0002-9] [Medline: 16525792]
6. Anderson G. Chronic conditions: making the case for ongoing care. Baltimore, MD: John Hopkins University; 2004.
URL:http://www.partnershipforsolutions.org/DMS/files/chronicbook2004.pdf [accessed 2014-10-07] [WebCite Cache ID
6T9AxSEqX]
7. National Center for Chronic Disease Prevention and Health Promotion. The Power of Prevention: Chronic disease...the
public health challenge of the 21st century. 2009. URL:http://www.cdc.gov/chronicdisease/pdf/2009-power-of-prevention.
pdf [accessed 2014-10-07] [WebCite Cache ID 6T9Ae4VeM]
8. Kay M. mHealth: New horizons for health through mobile technologies. Geneva, Switzerland: World Health Organization;
2011. URL:http://www.who.int/goe/publications/goe_mhealth_web.pdf [accessed 2014-11-22] [WebCite Cache ID
6UI1bwIeC]
9. Istepanaian RS, Zhang YT. Guest editorial. Introduction to the special section: 4G Health--the long-term evolution of
m-Health. IEEE Trans Inf Technol Biomed 2012 Jan;16(1):1-5. [doi: 10.1109/TITB.2012.2183269] [Medline: 22271836]
10. Huang A, Chen C, Bian K, Duan X, Chen M, Gao H, et al. WE-CARE: an intelligent mobile telecardiology system to
enable mHealth applications. IEEE J Biomed Health Inform 2014 Mar;18(2):693-702. [doi: 10.1109/JBHI.2013.2279136]
[Medline: 24608067]
11. Klasnja P, Pratt W. Healthcare in the pocket: mapping the space of mobile-phone health interventions. J Biomed Inform
2012 Feb;45(1):184-198 [FREE Full text] [doi: 10.1016/j.jbi.2011.08.017] [Medline: 21925288]
J Med Internet Res 2015 | vol. 17 | iss. 2 | e9 | p. 9http://www.jmir.org/2015/2/e9/
(page number not for citation purposes)
Nasi et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
12. Bender JL, Yue RY, To MJ, Deacken L, Jadad AR. A lot of action, but not in the right direction: systematic review and
content analysis of smartphone applications for the prevention, detection, and management of cancer. J Med Internet Res
2013;15(12):e287 [FREE Full text] [doi: 10.2196/jmir.2661] [Medline: 24366061]
13. European Commission. A Digital Agenda for Europe. Brussels, Europe URL:http://ec.europa.eu/digital-agenda/ [accessed
2014-09-25] [WebCite Cache ID 6Ss4C76xb]
14. Office of the National Coordinator for Health Information Technology. Federal Health IT Strategic Plan. URL:http://www.
healthit.gov/sites/default/files/utility/final-federal-health-it-strategic-plan-0911.pdf [accessed 2014-11-22] [WebCite Cache
ID 6UI0VipN8]
15. International Agency for Research on Cancer. GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence
worldwide in 2012.: World Health Organization URL:http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx [accessed
2014-08-03] [WebCite Cache ID 6RbL8TOTq]
16. Chao CC, Jen WY, Hung MC, Li YC, Chi YP. An innovative mobile approach for patient safety services: The case of a
Taiwan health care provider. Technovation 2007 Jun;27(6-7):342-351. [doi: 10.1016/j.technovation.2006.12.008]
17. Pare XG, Sicotte C, Moreault MP, Poba-Nzaou P, Templier M, Nahas G. Effects of Mobile Computing on the Quality of
Homecare Nursing Practice. : IEEE; 2011 Presented at: Hawaii International Conference on System Sciences (HICSS);
Jan. 4-7, 2011; Kauai, HI p. 1-11. [doi: 10.1109/HICSS.2011.179]
18. Fife E, Pereira F. Digital home health and mHealth: Prospects and challenges for adoption in the U.S. : IEEE; 2011 Presented
at: FITCE Congress (FITCE); Aug. 31-Sept. 3, 2011; Palermo p. 1-11. [doi: 10.1109/FITCE.2011.6133431]
19. Wilcox L, Patel R, Chen Y, Shachak A. Human factors in computing systems: focus on patient-centered health communication
at the ACM SIGCHI conference. Patient Educ Couns 2013 Dec;93(3):532-534. [doi: 10.1016/j.pec.2013.09.017] [Medline:
24184039]
20. Hamou A, Guy S, Lewden B, Bilyea A, Gwadry-Sridhar F, Bauer M. Data collection with iPhone Web apps efficiently
collecting patient data using mobile devices. 2010 Presented at: 12th IEEE International Conference on e-Health Networking
Applications and Services (Healthcom); July 1-3, 2010; Lyon p. 235-239. [doi: 10.1109/HEALTH.2010.5556565]
21. Cucciniello M, Nasi G, Valotti G. Assessing Transparency in Government: Rhetoric, Reality and Desire. : IEEE; 2012
Presented at: 45th Hawaii International Conference on System Science (HICSS); Jan. 4-7, 2012; Maui, HI p. 2451-2461.
[doi: 10.1109/HICSS.2012.123]
22. Cucciniello M, Nasi G. Transparency for Trust in Government: How Effective is Formal Transparency? International
Journal of Public Administration 2014;37(13):911-921. [doi: 10.1080/01900692.2014.949754]
23. Kearney N, McCann L, Norrie J, Taylor L, Gray P, McGee-Lennon M, et al. Evaluation of a mobile phone-based, advanced
symptom management system (ASyMS) in the management of chemotherapy-related toxicity. Support Care Cancer 2009
Apr;17(4):437-444. [doi: 10.1007/s00520-008-0515-0] [Medline: 18953579]
24. Panayi ND, Mars MM, Burd R. The promise of digital (mobile) health in cancer prevention and treatment. Future Oncol
2013 May;9(5):613-617. [doi: 10.2217/fon.13.42] [Medline: 23647287]
25. Varshney U. Smart medication management system and multiple interventions for medication adherence. Decision Support
Systems 2013 May;55(2):538-551. [doi: 10.1016/j.dss.2012.10.011]
26. Heinrich C, Kuiper RA. Using Handheld Devices to Promote Medication Adherence in Chronic Illness. The Journal for
Nurse Practitioners 2012 Apr;8(4):288-293. [doi: 10.1016/j.nurpra.2011.10.010]
27. Leimeister JM, Daum M, Krcmar H. Towards m-communities: the case of COSMOS healthcare. 2003 Presented at: 36th
Annual Hawaii International Conference on System Sciences (HICSS); Jan. 6-9, 2003; Hawaii. [doi:
10.1109/HICSS.2003.1174572]
28. Dwivedi A, Bali RK, James AE, Naguib RNG. Workflow management systems: the healthcare technology of the future?
In: Proceedings of the 23rd Annual International Conference of the IEEE Engineering in Medicine and Biology Society.
2001 Presented at: 23rd Annual International Conference of the IEEE; Oct. 25-28, 2001; Istanbul p. 3887-3890. [doi:
10.1109/IEMBS.2001.1019689]
29. Choi J, Yoo S, Park H, Chun J. MobileMed: A PDA-Based Mobile Clinical Information System. IEEE Trans Inform Technol
Biomed 2006 Jul;10(3):627-635. [doi: 10.1109/TITB.2006.874201]
30. Fiordelli M, Diviani N, Schulz PJ. Mapping mHealth research: a decade of evolution. J Med Internet Res 2013;15(5):e95
[FREE Full text] [doi: 10.2196/jmir.2430] [Medline: 23697600]
31. Baumgart DC. Personal digital assistants in health care: experienced clinicians in the palm of your hand? Lancet 2005 Oct
1;366(9492):1210-1222. [doi: 10.1016/S0140-6736(05)67484-3] [Medline: 16198770]
32. Gurol-Urganci I, de Jongh T, Vodopivec-Jamsek V, Atun R, Car J. Mobile phone messaging reminders for attendance at
healthcare appointments. Cochrane Database Syst Rev 2013;12:CD007458. [doi: 10.1002/14651858.CD007458.pub3]
[Medline: 24310741]
33. Litan RE. Remote health monitoring transmits savings, enhances lives. 2008. URL:https://www.corp.att.com/healthcare/
docs/litan.pdf [accessed 2014-11-23] [WebCite Cache ID 6UJ707Zw0]
34. Boston Consulting GroupTelenor Group. Socio-Economic Impact of mhealth. 2012. URL:http://www.telenor.com/wp-content/
uploads/2012/05/BCG-Telenor-Mobile-Health-Report-May-20121.pdf [accessed 2014-08-05] [WebCite Cache ID
6RbODMSvy]
J Med Internet Res 2015 | vol. 17 | iss. 2 | e9 | p. 10http://www.jmir.org/2015/2/e9/
(page number not for citation purposes)
Nasi et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
35. Richter JG, Nixdorf M, Becker A, Koch T, Monser R, Schneider M. Mobile Computing instead of paper based documentation
in German Rheumatology. : IEEE; 2006 Presented at: ICMB '06. International Conference on Mobile Business; June 25-7,
2006; Copenhagen p. 28-28. [doi: 10.1109/ICMB.2006.33]
36. Kumar S, Nilsen WJ, Abernethy A, Atienza A, Patrick K, Pavel M, et al. Mobile health technology evaluation: the mHealth
evidence workshop. Am J Prev Med 2013 Aug;45(2):228-236 [FREE Full text] [doi: 10.1016/j.amepre.2013.03.017]
[Medline: 23867031]
37. Stoner SA, Hendershot CS. A randomized trial evaluating an mHealth system to monitor and enhance adherence to
pharmacotherapy for alcohol use disorders. Addict Sci Clin Pract 2012;7:9 [FREE Full text] [doi: 10.1186/1940-0640-7-9]
[Medline: 23186301]
38. Vasbinder EC, Janssens HM, Rutten-van Mölken MP, van Dijk L, de Winter BC, de Groot RC, e-MATIC Study Group.
e-Monitoring of asthma therapy to improve compliance in children using a real-time medication monitoring system (RTMM):
the e-MATIC study protocol. BMC Med Inform Decis Mak 2013;13:38 [FREE Full text] [doi: 10.1186/1472-6947-13-38]
[Medline: 23514242]
39. Cleland JG, Louis AA, Rigby AS, Janssens U, Balk AH, TEN-HMS Investigators. Noninvasive home telemonitoring for
patients with heart failure at high risk of recurrent admission and death: the Trans-European Network-Home-Care Management
System (TEN-HMS) study. J Am Coll Cardiol 2005 May 17;45(10):1654-1664 [FREE Full text] [doi:
10.1016/j.jacc.2005.01.050] [Medline: 15893183]
40. Snell A, Smalley J. Reducing Hospital Readmissions via Remote Patient Management, Hospital and Physician Relations
Executive Summit. Smalley; 2013. URL:http://telehealthtechnology.org/sites/default/files/documents/webinars/
Snell-Smalley_Hospital%20-Physician-Summit-Feb-2013.pdf [accessed 2014-08-05] [WebCite Cache ID 6RbO5g31L]
41. Goldberg LR, Piette JD, Walsh MN, Frank TA, Jaski BE, Smith AL, WHARF Investigators. Randomized trial of a daily
electronic home monitoring system in patients with advanced heart failure: the Weight Monitoring in Heart Failure (WHARF)
trial. Am Heart J 2003 Oct;146(4):705-712. [doi: 10.1016/S0002-8703(03)00393-4] [Medline: 14564327]
42. Wickramasinghe N, Chalasani S, Goldberg S, Koritala S. Applying a Pervasive Technology Solution to Facilitate Better
Healthcare Delivery to Native American Patients: The Example of DiaMonD. 2011 Presented at: 44th Hawaii International
Conference on System Sciences (HICSS); Jan. 4-7, 2011; Kauai, HI p. 1-10. [doi: 10.1109/HICSS.2011.70]
43. Akter S, D’Ambra J, Ray P. Development and validation of an instrument to measure user perceived service quality of
mHealth. Information & Management 2013 Jun;50(4):181-195. [doi: 10.1016/j.im.2013.03.001]
44. Brown W, Yen PY, Rojas M, Schnall R. Assessment of the Health IT Usability Evaluation Model (Health-ITUEM) for
evaluating mobile health (mHealth) technology. Journal of Biomedical Informatics 2013 Dec;46(6):1080-1087. [doi:
10.1016/j.jbi.2013.08.001]
45. Hassan SA. Medical Quality-of-Service Optimization in Wireless Telemedicine System Using Optimal Smoothing Algorithm.
ETSN 2013;02(01):1-8. [doi: 10.4236/etsn.2013.21001]
46. Shegog R, Bamps YA, Patel A, Kakacek J, Escoffery C, Johnson EK, et al. Managing Epilepsy Well: Emerging e-Tools
for epilepsy self-management. Epilepsy Behav 2013 Oct;29(1):133-140. [doi: 10.1016/j.yebeh.2013.07.002] [Medline:
23948657]
47. Appelboom G, Yang AH, Christophe BR, Bruce EM, Slomian J, Bruyère O, et al. The promise of wearable activity sensors
to define patient recovery. J Clin Neurosci 2014 Jul;21(7):1089-1093. [doi: 10.1016/j.jocn.2013.12.003] [Medline: 24534628]
48. Leijdekkers P, Gay V. User adoption of mobile apps for chronic disease management: a case study based on
myfitnesscompanion®. In: Impact Analysis of Solutions for Chronic Disease Prevention and Management. Berlin, Heidelberg:
Springer; 2012:42-49.
49. Walker RM, Damanpour F, Devece CA. Management Innovation and Organizational Performance: The Mediating Effect
of Performance Management. Journal of Public Administration Research and Theory 2010 Aug 18;21(2):367-386. [doi:
10.1093/jopart/muq043]
50. Cucciniello M, Nasi G. Evaluation of the Impacts of Innovation in the Health Care Sector: A comparative analysis. Public
Management Review 2013 Jun 14;16(1):90-116. [doi: 10.1080/14719037.2013.798026]
51. Free C, Phillips G, Galli L, Watson L, Felix L, Edwards P, et al. The effectiveness of mobile-health technology-based health
behaviour change or disease management interventions for health care consumers: a systematic review. PLoS Med
2013;10(1):e1001362 [FREE Full text] [doi: 10.1371/journal.pmed.1001362] [Medline: 23349621]
52. WHOQoL Group. The World Health Organization Quality of Life Assessment (WHOQOL): development and general
psychometric properties. Soc Sci Med 1998 Jun;46(12):1569-1585. [Medline: 9672396]
53. Cucciniello M, Nasi G. Evaluation of the Impacts of Innovation in the Health Care Sector: A comparative analysis. Public
Management Review 2013 Jun 14;16(1):90-116. [doi: 10.1080/14719037.2013.798026]
54. Holzinger A, Kosec P, Schwantzer G, Debevc M, Hofmann-Wellenhof R, Frühauf J. Design and development of a mobile
computer application to reengineer workflows in the hospital and the methodology to evaluate its effectiveness. J Biomed
Inform 2011 Dec;44(6):968-977 [FREE Full text] [doi: 10.1016/j.jbi.2011.07.003] [Medline: 21854873]
55. Mohammadzadeh N, Safdari R, Rahimi A. Cancer Care Management through a Mobile Phone Health Approach: Key
Considerations. Asian Pacific Journal of Cancer Prevention 2013 Sep 30;14(9):4961-4964. [doi:
10.7314/Apjcp.2013.14.9.4961]
J Med Internet Res 2015 | vol. 17 | iss. 2 | e9 | p. 11http://www.jmir.org/2015/2/e9/
(page number not for citation purposes)
Nasi et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
56. Lamber P, Ludwig B, Ricci F, Zini F, Mitterer M. Message-Based Patient Guidance in Day-Hospital. : IEEE; 2011 Presented
at: 12th IEEE International Conference on Mobile Data Management (MDM); June 6-9, 2011; Lulea, Sweden p. 162-167.
[doi: 10.1109/MDM.2011.77]
57. Nabhani-Gebara S, Kayyali R, Olszewska A. 84 Patients' Perception of Educational Material Surrounding Their Cancer
Treatment. European Journal of Oncology Nursing 2012 Apr;16:S30. [doi: 10.1016/S1462-3889(12)70096-0]
58. Greaney ML, Puleo E, Sprunck-Harrild K, Bennett GG, Cunningham MA, Gillman MW, et al. Electronic reminders for
cancer prevention: factors associated with preference for automated voice reminders or text messages. Prev Med 2012
Aug;55(2):151-154 [FREE Full text] [doi: 10.1016/j.ypmed.2012.05.014] [Medline: 22659227]
59. Mooney KH, Beck SL, Friedman RH, Farzanfar R. Telephone-linked care for cancer symptom monitoring: a pilot study.
Cancer Pract 2002;10(3):147-154. [Medline: 11972569]
60. Becker S, Kribben A, Meister S, Diamantidis CJ, Unger N, Mitchell A. User profiles of a smartphone application to support
drug adherence--experiences from the iNephro project. PLoS One 2013;8(10):e78547 [FREE Full text] [doi:
10.1371/journal.pone.0078547] [Medline: 24194946]
61. Vodopivec-Jamsek V, de Jongh T, Gurol-Urganci I, Atun R, Car J. Mobile phone messaging for preventive health care.
Cochrane Database Syst Rev 2012;12:CD007457. [doi: 10.1002/14651858.CD007457.pub2] [Medline: 23235643]
62. van Heerden A, Tomlinson M, Swartz L. Point of care in your pocket: a research agenda for the field of m-health. Bull
World Health Organ 2012 May 1;90(5):393-394 [FREE Full text] [doi: 10.2471/BLT.11.099788] [Medline: 22589575]
63. Tomlinson M, Rotheram-Borus MJ, Swartz L, Tsai AC. Scaling up mHealth: where is the evidence? PLoS Med
2013;10(2):e1001382 [FREE Full text] [doi: 10.1371/journal.pmed.1001382] [Medline: 23424286]
64. Cristofoli D, Nasi G, Turrini A, Valotti G. Civil Service Reforms in Italy: The Importance of External Endorsement and
Administrative Leadership. Governance 2011;24:261-283. [doi: 10.1111/j.1468-0491.2011.01524.x]
65. Nasi G, Frosini F, Cristofoli D. Online service provision: are municipalities really innovative? The case of larger municipalities
in Italy. Public Administration 2011;89:821-839. [doi: 10.1111/j.1467-9299.2010.01865.x]
66. Cucciniello M, Nasi G. L'attuazione dell'e-government in Italia: retorica o realtà?. Milano: Egea; 2008.
67. Nasi G. Innovazione e cambiamento nelle aziende del settore pubblico. Milano: Egea; 2008.
68. Nasi G. Misurare e valutare l'innovazione nelle aziende pubbliche. Milano: Egea; 2014.
Abbreviations
mHealth:  mobile health
PDA:  personal digital assistant
SMS:  short message service
Edited by G Eysenbach,R Tarricone; submitted 07.08.14; peer-reviewed by E Huang, X Pastor; comments to author 24.09.14; accepted
29.09.14; published 13.02.15
Please cite as:
Nasi G, Cucciniello M, Guerrazzi C
The Performance of mHealth in Cancer Supportive Care: A Research Agenda
J Med Internet Res 2015;17(2):e9
URL: http://www.jmir.org/2015/2/e9/
doi: 10.2196/jmir.3764
PMID: 25720295
©Greta Nasi, Maria Cucciniello, Claudia Guerrazzi. Originally published in the Journal of Medical Internet Research
(http://www.jmir.org), 13.02.2015. This is an open-access article distributed under the terms of the Creative Commons Attribution
License (http://creativecommons.org/licenses/by/2.0/), which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work, first published in the Journal of Medical Internet Research, is properly cited. The complete
bibliographic information, a link to the original publication on http://www.jmir.org/, as well as this copyright and license information
must be included.
J Med Internet Res 2015 | vol. 17 | iss. 2 | e9 | p. 12http://www.jmir.org/2015/2/e9/
(page number not for citation purposes)
Nasi et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
